%0 Journal Article %A Li, Fujun %A Miao, Lixia %A Xue, Teng %A Qin, Hao %A Mondal, Santanu %A Thompson, Paul %A Coonrod, Scott %A Liu, Xiaoqiu %A Zhang, Xuesen %D 2019 %T MOESM7 of Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells %U https://springernature.figshare.com/articles/journal_contribution/MOESM7_of_Inhibiting_PAD2_enhances_the_anti-tumor_effect_of_docetaxel_in_tamoxifen-resistant_breast_cancer_cells/9969263 %R 10.6084/m9.figshare.9969263.v1 %2 https://springernature.figshare.com/ndownloader/files/17958782 %K Breast cancer %K Tamoxifen-resistance %K PAD2 %K Docetaxel %X Additional file 7. Figure S7. Western blot analysis showing that pretreatment of PAD2 knockdown (a) or miR-125b-5p overexpression (b) MCF7/TamR cells with 10 ÎźM MHY1485 abolished the inhibitory effect of docetaxel on Rps6 activation. GAPDH served as loading control; shPAD2: PAD2 knockdown MCF7/TamR cells; miR-125b-5p: miR-125b-5p overexpression MCF7/TamR cells; Doc: docetaxel; PBS was used as a control. %I figshare